Featured
Portfolio Companies
Partnering with highly experienced management teams, we strategically guide and support their successes as we seek to lead growing, strong revenue-generating healthcare companies.
Germfree
Modular and mobile cleanroom and biocontainment facilities for pharmaceutical, biotech companies and hospitals
Boiron
French natural medicine company offering a portfolio of natural, science-based innovative and personalized pharmaceutical products
Enercon Technologies
Electronics product development and contract manufacturing partner specializing in medical devices
Prolacta
Pharmaceutical-grade human milk processing for premature babies in hospital neonatal intensive care units
Sectors of Focus
Pharmaceuticals
Expanding specialty pharma sector, increasing sales of biologics and generics, and robust M&A market are supported by increasing insurance coverage and innovation within the pharmaceuticals sector
MedTech
Driven by a focus on healthcare outcomes and cost-effectiveness, technological advancements and a positive regulatory environment are merging within the convergence of IT and medical devices
Tech-Enabled Services
With increasing emphasis on personalized and remote care, tech-enabled services leverage advanced technologies through better monitoring, data analysis and personalized treatment options
Testimonials and endorsements reflect portfolio company management’s opinions and beliefs regarding the company and the investment. Such opinions and beliefs are subjective, do not represent a complete assessment of the company, the market or EW’s overall investment performance and cannot be independently verified. Such statements are being offered as references for purposes of demonstrating the benefits of working with the EW team and not for the purpose of soliciting investors. Portfolio company executives receive/received a salary and economics from the portfolio company. No executives were paid for their testimonial or endorsement. There is a conflict of interest in these unpaid testimonials and endorsements in that all speakers stand to benefit from EW’s success and they work/worked for an EW portfolio company.
Latest News & Insights
FDA Approves First Human Milk-Based Fortifier for Term Infants to Support Growth and Recovery Following Surgery for Gastroschisis
DUARTE, California—/PRNewswire/—Prolacta Bioscience, the...
EW Healthcare Partners Announces Leadership Evolution
• Dr. Petri Vainio to become Executive Chairman • Dr. Evis...
Ascend Advanced Therapies Partners with EW Healthcare Partners to Expand United States Capacity and Capabilities
London, United Kingdom –– Ascend Advanced Therapies...